Important notice regarding the forthcoming 42th JSHCT Annual meeting in Tokyo

February 25, 2020

Dear Colleagues:
We regret having to cancel the 42nd Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation scheduled on March 5-7, 2020. We are very sorry to inform you this decision at the last moment.

The decision was made based upon the recent endemic of novel coronavirus infection (COVID-19) that has not been under control yet and kept spreading out. We truly sorry for making this decision and deeply apologize for all the inconvenience that you may have. The decision was made in consideration of not only health issues of attendees, but also the public safety issues that the majority of attendees are heavily involved in the care of their immunocompromised patients.

Further information regarding issues caused by this meeting cancellation will be notified as it’s decided.

We appreciate your kind understanding and cooperation, and sincerely hope this global threat of infection will be over soon.

Shuichi Taniguchi, MD, PhD
President of the 42nd Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation
Shinichiro Okamoto, MD, PhD
Chairman of the Board, the Japan Society for Hematopoietic Cell Transplantation

What's New

Program is available.
Information for Presenters is available.
Online registration is closed.
Deadline for the Registration has been extended.
Registration is now open.
Call for Abstracts is closed.
Deadline for the Call for Abstracts has been extended.
Call for Abstracts is now open.
Website has been opened.


Department of Hematology, Toranomon Hospital
2-2-2 Toranomon, Minato-ku, Tokyo 105-8470, Japan
Congress Secretariat
c/o JTB Communication Design, Inc.
Address: Celestine Shiba Mitsui Bldg. 3-23-1, Shiba, Minato-ku, Tokyo 105-8335, Japan